Protagenic Therapeutics, Inc. (PTIX)
0.46
-0.01
(-2.52%)
USD |
OTCM |
Nov 13, 16:00
Protagenic Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2011 | 7.20% |
| June 30, 2011 | 13.22% |
| March 31, 2011 | 13.68% |
| December 31, 2010 | -47.40% |
| September 30, 2010 | 46.45% |
| June 30, 2010 | 41.43% |
| March 31, 2010 | 37.16% |
| December 31, 2009 | 41.13% |
| September 30, 2009 | 29.67% |
| June 30, 2009 | 32.51% |
| March 31, 2009 | 27.68% |
| December 31, 2008 | -6.11% |
| September 30, 2008 | 26.81% |
| June 30, 2008 | 39.29% |
| March 31, 2008 | 49.59% |
| December 31, 2007 | 90.05% |
| Date | Value |
|---|---|
| September 30, 2007 | 86.60% |
| June 30, 2007 | 78.33% |
| March 31, 2007 | 87.13% |
| December 31, 2006 | 95.86% |
| September 30, 2006 | 97.81% |
| June 30, 2006 | 95.98% |
| March 31, 2006 | 97.95% |
| April 30, 2003 | 45.70% |
| July 31, 2002 | 40.10% |
| April 30, 2002 | 45.84% |
| January 31, 2002 | 44.88% |
| October 31, 2001 | 42.12% |
| April 30, 2001 | 43.03% |
| January 31, 2001 | 47.28% |
| October 31, 2000 | 47.13% |
| January 31, 2000 | 43.66% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 156.0% |
| Return on Invested Capital | 445.2% |
| Return on Net Operating Assets | 258.0% |